Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155406948> ?p ?o ?g. }
- W2155406948 endingPage "228" @default.
- W2155406948 startingPage "217" @default.
- W2155406948 abstract "Commercial grade propylene glycol monomethyl ether (PGME), which is composed of > 99.5% alpha-isomer and < 0.5% beta-isomer, has been shown in several studies to have a low potential for developmental toxicity. Nonetheless, questions have been raised about potential human developmental toxicity due to beta-PGME, because it can be metabolized to 2-methoxypropionic acid (MPA), a compound bearing structural similarity to the teratogen, methoxyacetic acid (MAA). Accordingly, a series of in vivo developmental toxicity, whole embryo culture, and in vivo pharmacokinetic experiments were conducted in New Zealand White rabbits (highly sensitive to these compounds) to better understand the developmental toxicity potential of MPA and the kinetics of its formation from beta-PGME. For the in vivo developmental toxicity studies, groups of 20 inseminated rabbits were gavaged with 0, 10, 26, or 78 mg/kg/day of MPA on gestation day (GD) 7-19, followed by fetal evaluation on GD 28. Results with MPA were compared with those of rabbits similarly dosed with 0, 2.5, 7.5, or 15 mg/kg/day of MAA. Developmental toxicity no-observable-effect levels (NOEL) were approximately 10-fold higher for MPA (26 mg/kg/day) than for MAA (2.5 mg/kg/day). Also, the severity of effects caused by MPA was less than that of MAA, and unlike MAA, MPA was not selectively toxic to the fetus. This differential toxicity was also seen in whole embryo cultures of GD 9 rabbit embryos, in which there were no adverse effects of MPA (1.0, 5.0 mM) or its parent compound, beta-PGME (0.5, 2.0 mM), but severe dysmorphogenesis in 100% of embryos cultured in 5.0 mM MAA. The pharmacokinetics study showed rapid and complete conversion of beta-PGME to MPA, with a relatively long elimination half-life (33-44 h) for MPA. However, peak and AUC concentrations of MPA in blood associated with the MPA LOEL dose of 78 mg/kg/day were 1.3 mM and 52.9 mM-h/l, respectively, suggesting a relatively high threshold based on internal dosimetry. Taken together, these data indicate a negligible risk of developmental toxicity due to MPA formation from the small amounts of beta-isomer present in commercial PGME." @default.
- W2155406948 created "2016-06-24" @default.
- W2155406948 creator A5013710022 @default.
- W2155406948 creator A5023828222 @default.
- W2155406948 creator A5026492876 @default.
- W2155406948 creator A5028822603 @default.
- W2155406948 creator A5051491025 @default.
- W2155406948 creator A5067203567 @default.
- W2155406948 creator A5073976785 @default.
- W2155406948 creator A5090842068 @default.
- W2155406948 date "2003-02-01" @default.
- W2155406948 modified "2023-10-09" @default.
- W2155406948 title "Significance of 2-Methoxypropionic Acid Formed from beta-Propylene Glycol Monomethyl Ether: Integration of Pharmacokinetic and Developmental Toxicity Assessments in Rabbits" @default.
- W2155406948 cites W174594366 @default.
- W2155406948 cites W1963773474 @default.
- W2155406948 cites W1975915520 @default.
- W2155406948 cites W1975979630 @default.
- W2155406948 cites W1977054375 @default.
- W2155406948 cites W1978239142 @default.
- W2155406948 cites W1982804332 @default.
- W2155406948 cites W1989314580 @default.
- W2155406948 cites W1992897439 @default.
- W2155406948 cites W2002617716 @default.
- W2155406948 cites W2003683923 @default.
- W2155406948 cites W2004788521 @default.
- W2155406948 cites W2007068120 @default.
- W2155406948 cites W2007225525 @default.
- W2155406948 cites W2013088639 @default.
- W2155406948 cites W2015904774 @default.
- W2155406948 cites W2017475122 @default.
- W2155406948 cites W2019491425 @default.
- W2155406948 cites W2053868673 @default.
- W2155406948 cites W2065501790 @default.
- W2155406948 cites W2069274113 @default.
- W2155406948 cites W2070677797 @default.
- W2155406948 cites W2078721583 @default.
- W2155406948 cites W2079742284 @default.
- W2155406948 cites W2093080472 @default.
- W2155406948 cites W2094819211 @default.
- W2155406948 cites W2126843316 @default.
- W2155406948 cites W2151187751 @default.
- W2155406948 cites W2197227471 @default.
- W2155406948 cites W2318141527 @default.
- W2155406948 cites W2325343629 @default.
- W2155406948 cites W2417864823 @default.
- W2155406948 cites W2729393025 @default.
- W2155406948 doi "https://doi.org/10.1093/toxsci/71.2.217" @default.
- W2155406948 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12563107" @default.
- W2155406948 hasPublicationYear "2003" @default.
- W2155406948 type Work @default.
- W2155406948 sameAs 2155406948 @default.
- W2155406948 citedByCount "20" @default.
- W2155406948 countsByYear W21554069482012 @default.
- W2155406948 countsByYear W21554069482015 @default.
- W2155406948 countsByYear W21554069482016 @default.
- W2155406948 countsByYear W21554069482018 @default.
- W2155406948 countsByYear W21554069482019 @default.
- W2155406948 countsByYear W21554069482021 @default.
- W2155406948 countsByYear W21554069482023 @default.
- W2155406948 crossrefType "journal-article" @default.
- W2155406948 hasAuthorship W2155406948A5013710022 @default.
- W2155406948 hasAuthorship W2155406948A5023828222 @default.
- W2155406948 hasAuthorship W2155406948A5026492876 @default.
- W2155406948 hasAuthorship W2155406948A5028822603 @default.
- W2155406948 hasAuthorship W2155406948A5051491025 @default.
- W2155406948 hasAuthorship W2155406948A5067203567 @default.
- W2155406948 hasAuthorship W2155406948A5073976785 @default.
- W2155406948 hasAuthorship W2155406948A5090842068 @default.
- W2155406948 hasBestOaLocation W21554069481 @default.
- W2155406948 hasConcept C112705442 @default.
- W2155406948 hasConcept C116263406 @default.
- W2155406948 hasConcept C150903083 @default.
- W2155406948 hasConcept C172680121 @default.
- W2155406948 hasConcept C178790620 @default.
- W2155406948 hasConcept C179335377 @default.
- W2155406948 hasConcept C185592680 @default.
- W2155406948 hasConcept C195289149 @default.
- W2155406948 hasConcept C207001950 @default.
- W2155406948 hasConcept C2779234561 @default.
- W2155406948 hasConcept C29730261 @default.
- W2155406948 hasConcept C33070731 @default.
- W2155406948 hasConcept C54355233 @default.
- W2155406948 hasConcept C55493867 @default.
- W2155406948 hasConcept C65290608 @default.
- W2155406948 hasConcept C86803240 @default.
- W2155406948 hasConcept C98274493 @default.
- W2155406948 hasConceptScore W2155406948C112705442 @default.
- W2155406948 hasConceptScore W2155406948C116263406 @default.
- W2155406948 hasConceptScore W2155406948C150903083 @default.
- W2155406948 hasConceptScore W2155406948C172680121 @default.
- W2155406948 hasConceptScore W2155406948C178790620 @default.
- W2155406948 hasConceptScore W2155406948C179335377 @default.
- W2155406948 hasConceptScore W2155406948C185592680 @default.
- W2155406948 hasConceptScore W2155406948C195289149 @default.
- W2155406948 hasConceptScore W2155406948C207001950 @default.
- W2155406948 hasConceptScore W2155406948C2779234561 @default.
- W2155406948 hasConceptScore W2155406948C29730261 @default.
- W2155406948 hasConceptScore W2155406948C33070731 @default.